StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) stock

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.72−0.03 (-1.71%)

Close on Nov 17, 2026Market cap $36.18MP/E –Yield –

Grace Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Grace Therapeutics's market cap was $30.19M on Nov 11, 2026, against $44.93M a year earlier. Over the last 5 years it ranged from $15.32M to $71.64M, with a median of $31.57M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$30.19M-38.2%
2025Dec 31, 2025$48.88M+15.1%
2024Dec 31, 2024$42.48M+96.5%
2023Dec 29, 2023$21.61M-15.1%
2022Dec 30, 2022$25.45M-14.9%
2021Dec 31, 2021$29.90M-0.0%
2020Dec 31, 2020$29.90M+218.6%
2019Apr 30, 2019$9.39M+4.6%
2018Dec 31, 2018$8.97M-11.8%
2017Dec 29, 2017$10.17M-23.7%
2016Dec 30, 2016$13.32M–

More Grace Therapeutics figures

See a number that looks wrong?